The association between mean platelet volume and poor outcome in patients with COVID-19: Systematic review,

Ahmad Fariz Malvi Zamzam Zein1,2, Catur Setiya Sulistiyana3, Wilson Matthew Raffaelo4

  • 1Department of Internal Medicine, Faculty of Medicine, Universitas Swadaya Gunung Jati, Cirebon, Indonesia.

PubMed

Insights

Increased mean platelet volume (MPV) is linked to severe COVID-19 outcomes and mortality. This finding suggests MPV could be a potential biomarker for disease severity. Further research is needed to establish optimal cut-off points.

Area of Science:

  • Hematology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • COVID-19 is a significant global health concern with varied clinical presentations.
  • Mean Platelet Volume (MPV) is an indicator of platelet activation and function.
  • The relationship between MPV and COVID-19 severity requires further elucidation.

Purpose of the Study:

  • To assess the association between mean platelet volume (MPV) and poor outcomes in COVID-19 patients.
  • To synthesize existing evidence through a meta-analysis.

Main Methods:

  • A comprehensive literature search was conducted across PubMed, Embase, and Scopus databases.
  • Keywords included "2019-nCoV", "SARS-CoV-2", "COVID-19", "mean platelet volume", and "MPV".
  • The primary outcome was a composite of severe COVID-19 or mortality, with pooled effect estimates reported as mean differences.

Main Results:

  • The meta-analysis included 17 studies with 4549 COVID-19 patients.
  • Higher MPV was observed in patients with poor outcomes (10.3 ± 1.9 fL) compared to those without (9.9 ± 1.7 fL).
  • Increased MPV was significantly associated with both severe COVID-19 and mortality, independent of age, gender, or other blood cell counts.

Conclusions:

  • Elevated MPV is associated with increased severity and mortality in COVID-19 patients.
  • MPV may serve as a potential prognostic biomarker for COVID-19.
  • Further research is recommended to determine the optimal MPV cut-off for predicting adverse outcomes.
Abstract